🔎 Trials Near Me

Почетна › Гојазност › Mičigen

Kliničke studije za Гојазност u državi Mičigen

31 studija za Гојазност traži učesnike na lokacijama u državi Mičigen.

Gradovi u državi Mičigen

Zvanični tekst studije (na engleskom)

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • Great Lakes Research Institute, Southfield
  • Arcturus Healthcare, Public Limited Company, Troy Internal Medicine Research Division, Troy
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

  • Revive Research Institute, Inc., Southfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07823608

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

  • Aa Mrc Llc, Flint
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07845500

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  • Profound Research LLC, Farmington Hills
  • Revive Research Institute, Inc., Sterling Heights
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Aa Mrc Llc, Flint
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  • David Fivenson, MD, PLC, Ann Arbor
  • The Derm Institute of West Michigan, Caledonia
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942

Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  • Helen Devos Childrens' Hospital - PIN, Grand Rapids
Тражи се учесникФаза 3
Узраст од 6 до 11 · Оба пола · Ажурирано 4. 11. 2026. · NCT07817875

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Great Lakes Research Institute, Southfield
  • Revive Research Institute, Inc., Southfield
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Revive Research Institute, Inc., Southfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07369011

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Helen Devos Childrens' Hospital - PIN, Grand Rapids
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Revival Research Institute, LLC, Dearborn
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Troy
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • University of Michigan Health System, Dominos Farms, Ann Arbor
  • Embassy Research Network, Bloomfield Township
  • Henry Ford Health System, Detroit
  • и још 3
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Farmington Hills
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • Profound Research, Farmington Hills
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973

Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents

  • University of Michigan, Ann Arbor
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 14 до 18 · Оба пола · Ажурирано 15. 10. 2026. · NCT06007404

The RESET System Pivotal Clinical Trial (Protocol Revision K)

  • Michigan Medicine, Division of Gastroenterology and Hepatology, Ann Arbor
Тражи се учесник
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Headlands Research - Detroit, Southfield
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Headlands Research - Detroit, Southfield
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Headlands Research - Detroit, Southfield
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Northern Pines Hlth Ctr, PC, Buckley
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07720271

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07321886

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Southfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • C.S. Mott University of Michigan, Ann Arbor
Тражи се учесникФаза 2
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Cardio and Vascular Assoc-CAVA, Bloomfield Hills
  • Corewell Health, Grand Rapids
  • University Of Michigan, Lansing
  • и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Arcturus Healthcare, PLC., Troy
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Ann Arbor
Тражи се учесникФаза 3
Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361

Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance

  • University of Michigan, Ann Arbor
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 15 до 75 · Оба пола · Ажурирано 13. 7. 2026. · NCT02043457

Michigan Weight Navigation Program (MiWeigh) Study

  • University of Michigan, Ann Arbor
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 6. 2026. · NCT07465341

Exercise Effects on Adipose Tissue Structure and Function

  • University of Michigan, Ann Arbor
Тражи се учесник
Узраст од 18 до 40 · Оба пола · Ажурирано 4. 6. 2026. · NCT04812314

Metabolic Adaptations to Weight Loss With and Without Exercise

  • University of Michigan, Ann Arbor
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 40 · Оба пола · Ажурирано 14. 4. 2026. · NCT05806801

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.